...
首页> 外文期刊>Evidence-Based Spine-Care Journal >Surgical Management of Giant Multilevel Aneurysmal Bone Cyst of Cervical Spine in a 10-Year-Old Child: Case Report with Review of Literature (Evid Based Spine Care J 2012;3(4):55–59)
【24h】

Surgical Management of Giant Multilevel Aneurysmal Bone Cyst of Cervical Spine in a 10-Year-Old Child: Case Report with Review of Literature (Evid Based Spine Care J 2012;3(4):55–59)

机译:10岁儿童颈椎巨大多级动脉瘤性骨囊肿的外科治疗:病例报告并文献复习(Evid Based Spine Care J 2012; 3(4):55–59)

获取原文

摘要

In response to the excellent case report and summary on aneurysmal bone cysts by Gurjar et al1 in the November 2012 edition of EBSJ, we felt that some additional points should be brought to the attention of the readers. In the management of these difficult but benign lesions, many good points were raised by the authors, but minimally invasive sclerotherapy was omitted. This procedure involves percutaneous puncturing, often repeated injections of a sclerosing agent, traditionally polidocanol and more recently ethanol, owing to complications reported with the former and not seen with the latter. It is a curious omission of the authors because one of the better articles considering sclerotherapy—“Is Sclerotherapy Better than Intralesional Excision for Treating Aneurysmal Bone Cysts?” by Varshney in CORR 2010—is from one of the author's institution, the All India Institute of Medical Sciences.2 In this Level II study, 94 patients were prospectively randomized into two treatment groups receiving either repetitive sclerotherapy using polidocanol or an intralesional extended curettage with autograft. With an average follow-up of more than 3 years, 93% achieved the group's criteria for healing versus 85% in the curettage control group, yet with a much more favorable complication profile. This injection-based treatment option has also been left unnoticed by other centers—as much as can be gleaned from the literature—as this form of therapy is likely not available in some institutions without more advanced interventional radiology departments.3 There is concern, however, regarding cervical aneurysmal bone cysts (ABCs) and injection of Ethibloc (polidocanol) following a case report resulting in death. This was felt to be related to tumor involvement with the vertebral artery.4 As noted by Gurjar, preoperative angiography, and if possible, embolization, are requisite studies.
机译:为了回应Gurjar等人在2012年11月版的EBSJ上发表的关于动脉瘤性骨囊肿的出色病例报告和摘要,我们认为应该提醒读者注意一些其他问题。在处理这些困难但良性的病变时,作者提出了许多优点,但省略了微创硬化疗法。由于前者报道的并发症而后者未见,该过程涉及经皮穿刺,通常要反复注射硬化剂,传统上是传统的多多酚和最近的乙醇。这是作者的一个奇怪的疏忽,因为考虑硬化疗法的更好的文章之一是“硬化疗法比动脉内切除术治疗动脉瘤性骨囊肿好吗?”由Varshney在CORR 2010中提供,来自作者的机构之一,全印度医学科学研究所。2在该II级研究中,将94例患者前瞻性地随机分为两个治疗组,分别接受使用波多克多醇的反复硬化治疗或病灶内刮除术。自体移植。平均随访3年以上,达到了该组的治愈标准的患者为93%,而刮宫对照组的这一比例为85%,但并发症情况更为有利。从其他文献中也可以发现,这种基于注射的治疗选择也没有被其他中心所注意到,因为在没有更先进的介入放射科的某些机构中,这种治疗形式可能无法获得。3然而,令人担忧的是,在导致死亡的病例报告之后,关于颈动脉瘤性骨囊肿(ABC)和注射Ethibloc(polidocanol)。认为这与肿瘤累及椎动脉有关。4正如古尔哈尔(Gurjar)所指出的,术前血管造影以及必要时栓塞是必要的研究。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号